Search Results 881-890 of 17806 for Hepatitis b

1. Safety Study of SEA-CD40 in Cancer Patients - Mayo Clinic

   Known positive for hepatitis B by surface antigen expression, or any other positive test for hepatitis B virus indicating acute or chronic infection; ...

2. Open-Label Study of PEGPH20 With CIS and GEM; PEGPH20 With Atezolizumab, CIS and GEM; and Compared With CIS and GEM Alone in HA-high Subjects With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma - Mayo Clinic

   Active hepatitis B virus (HBV) infection, defined as having a positive hepatitis B surface antigen (HBsAg) test at screening. Active hepatitis C virus ...

3. Liver problems - Doctors and departments - Mayo Clinic

   There are no doctors whose last name begins with the letter B B; Find a ... hepatitis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary ...

4. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

   Known to be seropositive for hepatitis B (defined by a positive test for hepatitis B surface antigen [HBsAg]). Subjects with resolved infection (e.g. ...

5. Study of ISB 1342, a CD38/​CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma - Mayo Clinic

   - Seronegative for hepatitis B antigen; positive hepatitis B tests can be further evaluated by confirmatory tests, and if viral load is negative, the ...

6. MAGNITUDE: a Phase 3 Study of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM) - Mayo Clinic

   * Has hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection * History of active malignancy within 3 years prior to screening * RNA ...

7. Nausea and vomiting In-depth - Mayo Clinic

   Hepatitis B · Hepatitis C · Hepatitis C: How common is sexual transmission? Hepatitis C: What happens in end-stage liver disease? Hidden Heart Attack ...

8. Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma - Mayo Clinic

   Participation eligibility · Patient with HBV or should be monitored for viral levels during study participation · Patient with detectable hepatitis B surface ...

9. A Phase 1B/​2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies (ARTACUS) - Mayo Clinic

   Active infection with hepatitis B virus (HBV), hepatitis C virus (HCV) or human immunodeficiency virus (HIV). Any history of transplant-related viral ...

10. A Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma - Mayo Clinic

    ... Hepatitis B infection must be tested. Subjects will be excluded if Hepatitis B surface antigen (HBS-Ag) is detected 15. Any Subject with a known history or ...